# Treatment of Chronic Fatigue Syndrome (CFS) With Iodinated Activated Charcoal (IodoCarb®)

> **NCT01793415** · PHASE1,PHASE2 · UNKNOWN · sponsor: **PharmaLundensis AB** · enrollment: 40 (estimated)

## Conditions studied

- Chronic Fatigue Syndrome

## Interventions

- **DRUG:** IodoCarb (r)
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01793415
- **Lead sponsor:** PharmaLundensis AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-02
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2013-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01793415

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01793415, "Treatment of Chronic Fatigue Syndrome (CFS) With Iodinated Activated Charcoal (IodoCarb®)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01793415. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*